|
HC-7366 Clinical Trials
2 actively recruiting trials across 2 locations
Tucson, Arizona1 trial
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
University of Arizona Cancer Center
Phase 1
Houston, Texas1 trial
Phase I Study of HC-7366 for Acute Myeloid Leukemia
MD Anderson Cancer Center
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.